DE69625918D1 - Lang wirksames mittel zur rektalen verabreichung - Google Patents

Lang wirksames mittel zur rektalen verabreichung

Info

Publication number
DE69625918D1
DE69625918D1 DE69625918T DE69625918T DE69625918D1 DE 69625918 D1 DE69625918 D1 DE 69625918D1 DE 69625918 T DE69625918 T DE 69625918T DE 69625918 T DE69625918 T DE 69625918T DE 69625918 D1 DE69625918 D1 DE 69625918D1
Authority
DE
Germany
Prior art keywords
rectal administration
long
effective agent
medicine
rectal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69625918T
Other languages
English (en)
Other versions
DE69625918T2 (de
Inventor
Osamu Kondo
Tomoko Fujimori
Shigeo Tanaka
Fumio Urushizaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69625918D1 publication Critical patent/DE69625918D1/de
Publication of DE69625918T2 publication Critical patent/DE69625918T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories
DE69625918T 1995-09-07 1996-09-04 Lang wirksames mittel zur rektalen verabreichung Expired - Fee Related DE69625918T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23015195 1995-09-07
PCT/JP1996/002497 WO1997009035A1 (fr) 1995-09-07 1996-09-04 Composition pour administration rectale a action de longue duree

Publications (2)

Publication Number Publication Date
DE69625918D1 true DE69625918D1 (de) 2003-02-27
DE69625918T2 DE69625918T2 (de) 2003-08-07

Family

ID=16903400

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69625918T Expired - Fee Related DE69625918T2 (de) 1995-09-07 1996-09-04 Lang wirksames mittel zur rektalen verabreichung

Country Status (9)

Country Link
US (1) US6136337A (de)
EP (1) EP0848948B1 (de)
KR (1) KR100428922B1 (de)
CN (1) CN1132573C (de)
AT (1) ATE231388T1 (de)
AU (1) AU707079B2 (de)
CA (1) CA2231176C (de)
DE (1) DE69625918T2 (de)
WO (1) WO1997009035A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010015708A (ko) * 1997-10-08 2001-02-26 우에하라 아끼라 좌제용 조성물
DE60133284T2 (de) * 2000-06-06 2009-03-26 Lequio Pharma Co.Ltd., Naha Medizinisches kombinationspräparat zur behandlung von verletztem abnormem gewebe
AU8803901A (en) * 2000-09-21 2002-04-02 Taisho Pharmaceutical Co Ltd Suppositories sustained in the lower rectum
US7115563B2 (en) * 2002-05-29 2006-10-03 Insignion Holding Limited Composition and its therapeutic use
US20040127861A1 (en) * 2002-12-26 2004-07-01 Bradley Pharmaceuticals, Inc. Method and apparatus for dispensing a composition
EP1666024A4 (de) * 2003-08-29 2009-11-25 Sato Pharma Präparat für die rektale verabreichung
US8436051B2 (en) * 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
CA2833420C (en) * 2011-04-26 2019-09-03 Rdd Pharma Ltd. Oxymetazoline for the treatment of ano-rectal disorders
CA3016981C (en) 2015-03-12 2023-06-27 Cristcot Llc Hydrocortisone acetate suppository formulation for treatment of disease
WO2017037508A1 (en) * 2015-09-03 2017-03-09 Moradi Asghar An anti hemorrhoid herbal composition for targetting hemorrhoids and a method of synthesizing the same
WO2017093788A1 (en) * 2015-12-03 2017-06-08 Moradi Asghar An anti fissure herbal composition for targeting fissure and method of synthesizing the same
US11344495B2 (en) 2018-09-04 2022-05-31 Babak Ghalili Veterinary cannabinoid, menthol and anesthetic compositions and methods
WO2021177939A1 (en) * 2020-03-02 2021-09-10 Babak Ghalili Veterinary cannabinoid, menthol and anesthetic compositions and methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593261A (en) * 1976-07-23 1981-07-15 Inveresk Res Int Controlled release suppository
JPS601281B2 (ja) * 1977-07-28 1985-01-14 日本化薬株式会社 坐剤
CA1207231A (en) * 1982-08-24 1986-07-08 Hans W. Zulliger Medicated suppository
JPH0623093B2 (ja) * 1984-11-05 1994-03-30 大正製薬株式会社 痔疾用坐剤
JPH07100651B2 (ja) * 1987-05-13 1995-11-01 大正製薬株式会社 坐 剤
JP2556071B2 (ja) * 1987-11-30 1996-11-20 大正製薬株式会社 坐 剤
JP2802330B2 (ja) * 1988-07-01 1998-09-24 株式会社資生堂 直腸投与組成物
JPH04164023A (ja) * 1990-10-29 1992-06-09 Wakoudou Kk 坐剤用基剤
JPH0640889A (ja) * 1992-07-24 1994-02-15 Nippon Oil & Fats Co Ltd 座薬製剤
JP3593716B2 (ja) * 1993-07-12 2004-11-24 大正製薬株式会社 痔疾治療用組成物

Also Published As

Publication number Publication date
CN1132573C (zh) 2003-12-31
EP0848948A1 (de) 1998-06-24
CN1199334A (zh) 1998-11-18
WO1997009035A1 (fr) 1997-03-13
AU707079B2 (en) 1999-07-01
DE69625918T2 (de) 2003-08-07
US6136337A (en) 2000-10-24
CA2231176C (en) 2008-04-01
AU6889196A (en) 1997-03-27
EP0848948B1 (de) 2003-01-22
KR19990044454A (ko) 1999-06-25
EP0848948A4 (de) 1998-12-30
CA2231176A1 (en) 1997-03-13
KR100428922B1 (ko) 2004-08-02
ATE231388T1 (de) 2003-02-15

Similar Documents

Publication Publication Date Title
DE69625918T2 (de) Lang wirksames mittel zur rektalen verabreichung
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
CY1113355T1 (el) Χρηση θεραπειας νευροτοξινης για θεραπευτικη αγωγη ουρολογικων και σχετικων διαταραχων
DE69941429D1 (de) 1-deoxy-galactonojirimycin-derivate zur vewendung bei der behandlung von lysosomalen speicherkrankheiten mittels steigerung der lysosomalen alpha galactosidase a
TR199701490A2 (xx) 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
ATE476155T1 (de) In-vitro herstellung von transplantierbarem knorpelgewebe
YU22794A (sh) Veterinarska kompozicija
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
DE69429536T2 (de) Analgetisches Mittel und dessen Verwendung
CY1114734T1 (el) Φαρμακευτικες συνθεσεις και μεθοδοι χρησιμες για ρυθμιση αγγειογενεσης
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
DE69619052D1 (de) Feste, wasserfreie, pharmazeutische Zubereitungen für vaginale Verwendung
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
EA199700381A1 (ru) Диароматические соединения пропинила или диенила, промежуточные соединения, фармацевтические и косметические композиции на основе указанных соединений и применение косметических композиций
ATE99669T1 (de) N-2,3-butadienyl-tri-aminoalkanderivate.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
DE59604491D1 (de) Polymerisierbare aromatische carbonsäuren und carbonsäureanhydride mit cyclischen carbonatgruppen sowie zubereitungen, enthaltend diese verbindungen
ATE75610T1 (de) Pharmazeutische zubereitung zur behandlung des bluthochdrucks.
ATE371446T1 (de) Zusammensetzungen zur verhinderung der adhäsion
NO991047D0 (no) Transdermal terapeutisk tilnµrming involverende en kombinasjon av aktive substanser inneholdende °striol
CY1114822T1 (el) Χρηση θεραπειας αλλαντικης τοξινης για τη θεραπευτικη αγωγη δυσλειτουργιας οξεος τυπου

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee